Use of advanced diagnostics, vaccines, and improvements in public policy can support stewardship programs and also help address AMR and COVID-19 on multiple fronts. Without widespread intervention, these dual health threats will continue to worsen, leading to adverse health outcomes and decreased antibiotic efficacy for future generations.
Highlights from ECCMID 2021
With an event-wide focus on major diagnostic and microbiological topics, multiple sessions centered around antimicrobial resistance (AMR). We’ve highlighted select AMR-focused sessions and research that were presented during the information-packed weekend.
The Ongoing Need for Group B Streptococcus Awareness
As a leading cause of sepsis, meningitis, and pneumonia in infants, expanding public and clinical awareness of GBS is crucial.
Diagnostics Help Physicians Treat Acute Gastroenteritis, a Leading Cause of Death Among Children Worldwide
Worldwide, acute gastroenteritis—defined as a rapid onset diarrheal disease with or without nausea, vomiting, fever, or abdominal pain—causes 1.34 million deaths in children under age five each year.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...